Phase II study of irinotecan combined with carboplatin in previously untreated small-cell lung cancer.

British Journal of Cancer
A KinoshitaNagasaki Thoracic Oncology Group (NTOG)

Abstract

To determine the efficacy and toxicity of irinotecan combined with carboplatin, we conducted a phase II trial. Eligibility criteria were: chemotherapy-naïve, small-cell lung cancer (SCLC), good performance status (PS: 0-2), age<or=75 years, and adequate organ function. The patients' characteristics were: male/female=56/5; PS 0/1/2=19/38/4; median age (range)=68 years(51-75 years); limited disease (LD)/extensive disease (ED)=27/34. The patients received irinotecan (50 mg m-2) on days 1, 8, and 15, and carboplatin (AUC 5, Chatelut formula) on day 1 every 4 weeks. In total, 61 patients were eligible and all were evaluated. In all, 31 patients were treated with four or more courses of chemotherapy. Of the patients, 17 showed a complete response (CR), 34 showed a partial response (PR), nine had stable disease (SD), and one had progressive disease (PD). The overall response rate was 84% (95% confidence interval (CI), 72-91%; LD 89%, ED 79%) and the CR rate was 28% (95%CI, 17-41%; LD 37%, ED 21%). The median time to tumour progression was 6.1 (LD 6.4, ED 5.4) months. The medial survival time was 15.0 (LD 20.0, ED 9.7) months, and the 2-year and 5-year survival rates were 31.1% (LD 48.1%, ED 17.7%) and 9.5% (LD 11.1%, ED 5.9%), respect...Continue Reading

References

Nov 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A H CalvertE Wiltshaw
Sep 1, 1985·Cancer Treatment Reviews·W C Rose, J E Schurig
Apr 19, 1995·Journal of the National Cancer Institute·E ChatelutR Bugat
Sep 1, 1996·Critical Reviews in Oncology/hematology·N MasudaM Fukuoka
Jun 1, 1997·Chest·C F Mountain, C M Dresler
Oct 7, 1997·Clinical Pharmacokinetics·S B Duffull, B A Robinson
Mar 21, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S KudohM Fukuoka
May 30, 1998·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J Lokich, N Anderson
Aug 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R S Go, A A Adjei
Jul 4, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M OkaS Kohno
Jan 11, 2002·The New England Journal of Medicine·Kazumasa NodaUNKNOWN Japan Clinical Oncology Group
Oct 12, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M OkaS Kohno
Jan 16, 2003·Chest·George R SimonUNKNOWN American College of Chest Physicians
Mar 1, 2003·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Filippo De MarinisUNKNOWN Foundation for Oncological Research
Jun 27, 2003·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Yoshihiko SegawaUNKNOWN Okayama Lung Cancer Study Group
Jan 1, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Martin J EdelmanDavid R Gandara
Jul 6, 2004·International Journal of Radiation Oncology, Biology, Physics·Steven E SchildJames R Jett
Aug 25, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Katsuyuki HottaMitsune Tanimoto
Sep 15, 2004·Cancer Chemotherapy and Pharmacology·Minoru FukudaUNKNOWN Nagasaki Thoracic Oncology Group
Jun 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Harvey B NiellUNKNOWN Cancer and Leukemia Group

❮ Previous
Next ❯

Citations

Sep 10, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andreas HermesSverre Sörenson
Dec 6, 2014·Hospital Pharmacy·Matthew R RutledgeDominic A Solimando
Mar 4, 2010·Medical Oncology·Young Saing KimDong Bok Shin
May 9, 2012·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·David R SpigelJohn D Hainsworth

❮ Previous
Next ❯

Methods Mentioned

BETA
X-ray

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.